Neonc Technologies Holdings, Inc. (NTHI)
NTHI Stock Price Chart
Explore Neonc Technologies Holdings, Inc. interactive price chart. Choose custom timeframes to analyze NTHI price movements and trends.
NTHI Company Profile
Discover essential business fundamentals and corporate details for Neonc Technologies Holdings, Inc. (NTHI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Mar 2025
Employees
8.00
Website
https://www.neonctech.comCEO
Thomas C. Chen
Description
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
NTHI Financial Timeline
Browse a chronological timeline of Neonc Technologies Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
NTHI Stock Performance
Access detailed NTHI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.